You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Alcohol-use disorders

Rifaximin for preventing episodes of overt hepatic encephalopathy

  • Technology appraisal guidance
  • Reference number: TA337
  • Published:  25 March 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Rifaximin for preventing episodes of overt hepatic encephalopathy: final appraisal determination document

Rifaximin for preventing episodes of overt hepatic encephalopathy:  final appraisal determination document Rifaximin for preventing episodes of overt hepatic encephalopathy: final appraisal determination document
19 February 2015
(306.73 Kb 29 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 17 February 2015

Back to top